These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33506478)

  • 41. Feasibility of Linking Area Deprivation Index Data to the OMOP Common Data Model.
    Jiang X; Beaton MA; Gillberg J; Williams A; Natarajan K
    AMIA Annu Symp Proc; 2022; 2022():587-595. PubMed ID: 37128466
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facilitating phenotype transfer using a common data model.
    Hripcsak G; Shang N; Peissig PL; Rasmussen LV; Liu C; Benoit B; Carroll RJ; Carrell DS; Denny JC; Dikilitas O; Gainer VS; Howell KM; Klann JG; Kullo IJ; Lingren T; Mentch FD; Murphy SN; Natarajan K; Pacheco JA; Wei WQ; Wiley K; Weng C
    J Biomed Inform; 2019 Aug; 96():103253. PubMed ID: 31325501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming electronic health record polysomnographic data into the Observational Medical Outcome Partnership's Common Data Model: a pilot feasibility study.
    Kim JW; Kim S; Ryu B; Song W; Lee HY; Yoo S
    Sci Rep; 2021 Mar; 11(1):7013. PubMed ID: 33782494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria.
    Si Y; Weng C
    Stud Health Technol Inform; 2017; 245():950-954. PubMed ID: 29295240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Query-handling in MLM-based decision support systems.
    Arkad K; Gao XM; Ahlfeldt H
    Med Inform (Lond); 1995; 20(3):229-40. PubMed ID: 8882561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of SNOMED CT as a Reference Terminology for Standardized Data Queries in the Arden Syntax.
    Jenders RA
    Stud Health Technol Inform; 2017; 245():1326. PubMed ID: 29295407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applying the OMOP Common Data Model to Facilitate Benefit-Risk Assessments of Medicinal Products Using Real-World Data from Singapore and South Korea.
    Tan HX; Teo DCH; Lee D; Kim C; Neo JW; Sung C; Chahed H; Ang PS; Tan DSY; Park RW; Dorajoo SR
    Healthc Inform Res; 2022 Apr; 28(2):112-122. PubMed ID: 35576979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EHR-Independent Predictive Decision Support Architecture Based on OMOP.
    Unberath P; Prokosch HU; Gründner J; Erpenbeck M; Maier C; Christoph J
    Appl Clin Inform; 2020 May; 11(3):399-404. PubMed ID: 32492716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformation of Pathology Reports Into the Common Data Model With Oncology Module: Use Case for Colon Cancer.
    Ryu B; Yoon E; Kim S; Lee S; Baek H; Yi S; Na HY; Kim JW; Baek RM; Hwang H; Yoo S
    J Med Internet Res; 2020 Dec; 22(12):e18526. PubMed ID: 33295294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mapping Local Biospecimen Records to the OMOP Common Data Model.
    Michael CL; Sholle ET; Wulff RT; Roboz GJ; Campion TR
    AMIA Jt Summits Transl Sci Proc; 2020; 2020():422-429. PubMed ID: 32477663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Data Integration into OMOP CDM for Heterogeneous Clinical Data Collections via HL7 FHIR Bundles and XSLT.
    Fischer P; Stöhr MR; Gall H; Michel-Backofen A; Majeed RW
    Stud Health Technol Inform; 2020 Jun; 270():138-142. PubMed ID: 32570362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of treatment pathways for three chronic diseases using OMOP CDM.
    Zhang X; Wang L; Miao S; Xu H; Yin Y; Zhu Y; Dai Z; Shan T; Jing S; Wang J; Zhang X; Huang Z; Wang Z; Guo J; Liu Y
    J Med Syst; 2018 Nov; 42(12):260. PubMed ID: 30421323
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EliIE: An open-source information extraction system for clinical trial eligibility criteria.
    Kang T; Zhang S; Tang Y; Hruby GW; Rusanov A; Elhadad N; Weng C
    J Am Med Inform Assoc; 2017 Nov; 24(6):1062-1071. PubMed ID: 28379377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A two-stage workflow to extract and harmonize drug mentions from clinical notes into observational databases.
    Almeida JR; Silva JF; Matos S; Oliveira JL
    J Biomed Inform; 2021 Aug; 120():103849. PubMed ID: 34214696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.
    Gruendner J; Schwachhofer T; Sippl P; Wolf N; Erpenbeck M; Gulden C; Kapsner LA; Zierk J; Mate S; Stürzl M; Croner R; Prokosch HU; Toddenroth D
    PLoS One; 2019; 14(10):e0223010. PubMed ID: 31581246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data.
    Dimitriadis VK; Gavriilidis GI; Natsiavas P
    Stud Health Technol Inform; 2021 May; 281():555-559. PubMed ID: 34042637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model.
    Matcho A; Ryan P; Fife D; Reich C
    Drug Saf; 2014 Nov; 37(11):945-59. PubMed ID: 25187016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Realism-Based View on Counts in OMOP's Common Data Model.
    Ceusters W; Blaisure J
    Stud Health Technol Inform; 2017; 237():55-62. PubMed ID: 28479543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generalizing the Arden Syntax to a Common Clinical Application Language.
    Kraus S
    Stud Health Technol Inform; 2018; 247():675-679. PubMed ID: 29678046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multi-model-based interactive authoring environment for creating shareable medical knowledge.
    Ali T; Hussain M; Ali Khan W; Afzal M; Hussain J; Ali R; Hassan W; Jamshed A; Kang BH; Lee S
    Comput Methods Programs Biomed; 2017 Oct; 150():41-72. PubMed ID: 28859829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.